Nineteen Republican lawmakers are taking a stand against what they consider disturbing practices at the National Institutes of Health (NIH). Led by Rep. Paul Gosar and joined by GOP Conference Chair Lisa McClain, they have sent a letter urging the House Appropriations Committee to eliminate all funding for transgender animal testing in the upcoming 2027 fiscal year budget. This move comes on the heels of revelations from the White Coat Waste Project, which found that the NIH allocated over $584,000 in January for a grant at the University of California—San Diego. This grant reportedly involves experiments to transgender mice.
The letter highlights the troubling nature of these experiments. It mentions that under the Biden Administration, NIH has issued grants to create “transfeminine” and “transmasculine” lab animals. These projects involve invasive surgeries and hormone treatments meant to replicate transgender experiences in humans, raising significant ethical concerns. According to the lawmakers, many female mice are subjected to painful procedures—such as ovary removal and testosterone injections—with projected impacts on nearly 10,000 animals. In a shocking turn, procedures also include skull drilling and injections of toxins.
Rep. Gosar stated, “Tax dollars shouldn’t be funding the Biden Administration’s sickening transgender animal tests.” His collaboration with White Coat Waste aims to curb the potential misuse of federal funds for what he calls “woke pseudoscience.” Justin Goodman, representing White Coat Waste, reinforced this sentiment. He pointed out that the NIH has resumed funding programs previously eliminated under President Trump, exposing concerns about bureaucratic defiance.
The White Coat Waste Project has been vocal about the misuse of taxpayer dollars, detailing how millions were previously allocated for controversial animal experiments. Their investigations, revealed alongside the recent funding report, show a pattern of funding for projects that include invasive testing on various species, raising alarms about ethical treatment standards. Surprisingly, officials from the Department of Health and Human Services (HHS) had assured earlier that such funding had ceased, which now appears to be contradicted.
The findings come at a critical juncture. While proponents of the research may argue for its potential scientific contributions, the moral implications surrounding the treatment of these animals cannot be overlooked. Uncovering such practices has led to calls for accountability and a reevaluation of funding priorities, particularly in an era where transparency in government spending is paramount.
This latest development pushes forward the discussion on the ethical landscape surrounding animal testing in research. As taxpayers grow increasingly aware of where their money is going, critiques of these practices are likely to intensify. The actions by Gosar and other lawmakers signal a growing concern not only about specific funding decisions but also about the broader implications of what such research symbolizes in current societal debates. The question remains: How far is too far when it comes to scientific inquiry, and who truly benefits in these scenarios?
"*" indicates required fields
